121 related articles for article (PubMed ID: 4058829)
1. Electrocoagulation and the risk of cervical neoplasia.
La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of cervical neoplasia.
La Vecchia C
Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
4. Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey.
Chanen W; Rome RM
Obstet Gynecol; 1983 Jun; 61(6):673-9. PubMed ID: 6843923
[TBL] [Abstract][Full Text] [Related]
5. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for cervico-uterine cancer in women in Zacatecas].
Castañeda-Iñiguez MS; Toledo-Cisneros R; Aguilera-Delgadillo M
Salud Publica Mex; 1998; 40(4):330-8. PubMed ID: 9774902
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for in situ cervical cancer: results from a case-control study.
Jones CJ; Brinton LA; Hamman RF; Stolley PD; Lehman HF; Levine RS; Mallin K
Cancer Res; 1990 Jun; 50(12):3657-62. PubMed ID: 2340514
[TBL] [Abstract][Full Text] [Related]
10. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
11. [Cervical dysplasia].
Tabachnik BI; Nikitina MA
Vopr Onkol; 1984; 30(3):21-8. PubMed ID: 6710945
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance.
Cheng RF; Hernandez E; Anderson LL; Heller PB; Shank R
J Reprod Med; 1999 Nov; 44(11):922-8. PubMed ID: 10589401
[TBL] [Abstract][Full Text] [Related]
13. Electrocoagulation diathermy for the treatment of cervical dysplasia and carcinoma in situ.
Hollyock VE; Chanen W
Obstet Gynecol; 1976 Feb; 47(2):196-9. PubMed ID: 1250542
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of cervical cancer screening in British Columbia.
Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
[No Abstract] [Full Text] [Related]
15. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
[TBL] [Abstract][Full Text] [Related]
16. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
Ogunbowale T; Lawoyin TO
Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
[TBL] [Abstract][Full Text] [Related]
18. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
Case AS; Rocconi RP; Straughn JM; Wang W; Roark K; Waltman EE; Huh WK
Obstet Gynecol; 2006 Dec; 108(6):1369-74. PubMed ID: 17138768
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of abnormal cervical cytology in a group of New Zealand women using contraception: a preliminary report. The New Zealand Contraception and Health Study Group.
N Z Med J; 1989 Jul; 102(872):369-71. PubMed ID: 2797552
[TBL] [Abstract][Full Text] [Related]
20. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
Højgaard Nielsen N; Jensen H; Hansen PK
Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
